Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study

Saved in:
Bibliographic Details
Published in:interactive Journal of Medical Research
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552952092819457
collection WordPress RSS
FRELIP Feed Integration
container_title interactive Journal of Medical Research
description
discipline_display Health and Safety
discipline_facet Health and Safety
format Online Article
RSS Article
genre Journal Article
id rss_article:69491
institution FRELIP
journal_source_facet interactive Journal of Medical Research
last_indexed 2026-06-20T21:29:00.958Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
Health and Safety
General
Health and Safety
sub_discipline_display General
sub_discipline_facet General
subject_display Health and Safety
General
Health and Safety
subject_facet Health and Safety
General
Health and Safety
title COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
title_alt Rebote de COVID-19 en grupos de tratamiento con nirmatrelvir más ritonavir y de control: estudio de cohorte prospectivo
Rebond du COVID-19 dans les groupes de traitement par nirmatrelvir plus ritonavir et témoins : étude de cohorte prospective
Rebote de COVID-19 em Grupos de Tratamento com Nirmatrelvir mais Ritonavir e Controle: Estudo de Coorte Prospectivo
title_auth COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
title_es_txt Rebote de COVID-19 en grupos de tratamiento con nirmatrelvir más ritonavir y de control: estudio de cohorte prospectivo
title_fr_txt Rebond du COVID-19 dans les groupes de traitement par nirmatrelvir plus ritonavir et témoins : étude de cohorte prospective
title_full COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
title_fullStr COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
title_full_unstemmed COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
title_pt_txt Rebote de COVID-19 em Grupos de Tratamento com Nirmatrelvir mais Ritonavir e Controle: Estudo de Coorte Prospectivo
title_short COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study
title_sort covid-19 rebound in nirmatrelvir plus ritonavir treatment and control groups: prospective cohort study
topic Health and Safety
General
Health and Safety
url https://www.i-jmr.org/2026/1/e80263